ConductScience.org, home

Paper40367190

Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy.

Borges B and 21 others. Sci Transl Med, 2025. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy. Papers, record 40367190. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40367190

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy.
PubMed
Journal
Sci Transl Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
5.66, provisional
iCite
Revised in PubMed
2026-08-29
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Borges BBeltranhttps://orcid.org/0009-0004-6730-0398
2Brown SMStephen Mhttps://orcid.org/0000-0002-1347-5908
3Chen WJWan-Jin
4Clarke MTMaria Thttps://orcid.org/0000-0002-1179-9466
5Herzeg AAkoshttps://orcid.org/0000-0002-2061-4099
6Park JHJae Honghttps://orcid.org/0000-0003-4561-3671
7Ross JJoshuahttps://orcid.org/0009-0005-7149-6706
8Kong LLinglinghttps://orcid.org/0000-0002-6266-9741
9Denton MMadeline
10Smith AKAmy Khttps://orcid.org/0009-0001-9717-5581
11Lum TTonyhttps://orcid.org/0009-0006-6652-2903
12Zada FMFareha Moulana
13Cordero MMarcohttps://orcid.org/0009-0004-1265-624X
14Gupta NNalin
15Cook SESarah E
16Murray HHeather
17Matson JJohnhttps://orcid.org/0009-0002-4489-1338
18Klein SStephaniehttps://orcid.org/0000-0002-8011-079X
19Bennett CFC Frank
20Krainer ARAdrian Rhttps://orcid.org/0000-0001-9024-9501

Source PubMed

See all 22 authorsDownload CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Oligonucleotides, AntisenseMajor topic
Muscular Atrophy, SpinalMajor topic
Amniotic FluidMajor topic
Animals
Disease Models, Animal
Mice
Female
Phenotype
Motor Neurons
Survival of Motor Neuron 1 Protein
Pregnancy
Humans
Sheep

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA045508NCI NIH HHSUnited StatesP30CA045508PubMed and NIHNIH RePORTER
R01 GM042699NIGMS NIH HHSUnited StatesR01GM042699PubMed and NIHNIH RePORTER
R35 NS122306NINDS NIH HHSUnited StatesR35NS122306PubMed and NIHNIH RePORTER
R37 GM042699NIGMS NIH HHSUnited StatesR01GM042699PubMed and NIHNIH RePORTER
R37GM042699NIHNIH RePORTER

Download CSV of grants

References73

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127683224Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouse.Nucleic Acids Res2016https://conductscience.org/library/papers/27683224PubMed
225911465Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele.Stem Cells Transl Med2015https://conductscience.org/library/papers/25911465PubMed
339189228Systematic Review of Presymptomatic Treatment for Spinal Muscular Atrophy.Int J Neonatal Screen2024https://conductscience.org/library/papers/39189228PubMed
418371932Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice.Am J Hum Genet2008https://conductscience.org/library/papers/18371932PubMed
521315257Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy.Neuron2011https://conductscience.org/library/papers/21315257PubMed
618455159Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy.Exp Neurol2008https://conductscience.org/library/papers/18455159PubMed
732409122Overturning the Paradigm of Spinal Muscular Atrophy as Just a Motor Neuron Disease.Pediatr Neurol2020https://conductscience.org/library/papers/32409122PubMed
828369979Population Pharmacokinetics of Nusinersen in the Cerebral Spinal Fluid and Plasma of Pediatric Patients With Spinal Muscular Atrophy Following Intrathecal Administrations.J Clin Pharmacol2017https://conductscience.org/library/papers/28369979PubMed
935715566Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.Nat Med2022https://conductscience.org/library/papers/35715566PubMed
1032248834Longitudinal natural history of type I spinal muscular atrophy: a critical review.Orphanet J Rare Dis2020https://conductscience.org/library/papers/32248834PubMed
1130188931Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice.PLoS One2018https://conductscience.org/library/papers/30188931PubMed
1238772209Cognitive function in SMA patients with 2 or 3 SMN2 copies treated with SMN-modifying or gene addition therapy during the first year of life.Eur J Paediatr Neurol2024https://conductscience.org/library/papers/38772209PubMed
1331704158Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study.Neuromuscul Disord2019https://conductscience.org/library/papers/31704158PubMed
1438827250Prenatal AAV9-GFP administration in fetal lambs results in transduction of female germ cells and maternal exposure to virus.Mol Ther Methods Clin Dev2024https://conductscience.org/library/papers/38827250PubMed
1531124209Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis.Ultrasound Obstet Gynecol2019https://conductscience.org/library/papers/31124209PubMed
1633505777Non-Invasive Strategies for Nose-to-Brain Drug Delivery.J Clin Trials2020https://conductscience.org/library/papers/33505777PubMed
1733626251Risdiplam in Type 1 Spinal Muscular Atrophy.N Engl J Med2021https://conductscience.org/library/papers/33626251PubMed
1811839954Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2.Genet Med2002https://conductscience.org/library/papers/11839954PubMed
1912077011Neuronal death is enhanced and begins during foetal development in type I spinal muscular atrophy spinal cord.Brain2002https://conductscience.org/library/papers/12077011PubMed
2018353472Biomedical applications of sheep models: from asthma to vaccines.Trends Biotechnol2008https://conductscience.org/library/papers/18353472PubMed

See all 73 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42573950Survival Motor Neuron Protein Requirement-Supply Mismatch in Spinal Muscular Atrophy: A Conceptual Framework.Adv Ther2026https://conductscience.org/library/papers/42573950PubMed
42458739Maternal-Fetal Administration of Risdiplam Partially Rescues the SMNΔ7 Mouse Model of Spinal Muscular Atrophy.Ann Neurol2026https://conductscience.org/library/papers/42458739PubMed
42410005Using human 3D organoid models to gain mechanistic insight in motor neuron diseases.Nat Rev Neurosci2026https://conductscience.org/library/papers/42410005PubMed
42310398Ten years of disease-modifying therapy in spinal muscular atrophy: lessons learned and future directions.Nat Rev Neurol2026https://conductscience.org/library/papers/42310398PubMed
41660305Progress in RNA-Targeted Therapeutics for Human Diseases.MedComm (2020)2026https://conductscience.org/library/papers/41660305PubMed
41489856Proband-independent noninvasive prenatal diagnosis for spinal muscular atrophy: early detection paving the way for early prenatal treatment.Ann Med2026https://conductscience.org/library/papers/41489856PubMed
41298837In utero precision medicine for severe, early-onset neurogenetic disease: scientific, clinical and ethical considerations.Pediatr Res2025https://conductscience.org/library/papers/41298837PubMed
41210168Systemic mRNA-LNP administration in fetuses improves survival in a mouse model of spinal muscular atrophy.Mol Ther Methods Clin Dev2025https://conductscience.org/library/papers/41210168PubMed
41137787Real-world evidence on nusinersen treatment of persons with SMA: a focused review.J Neuromuscul Dis2026https://conductscience.org/library/papers/41137787PubMed
41127529Chemically inducible antisense oligonucleotides for cell-specific gene silencing.RSC Chem Biol2025https://conductscience.org/library/papers/41127529PubMed
40906176Managing Spinal Muscular Atrophy: A Look at the Biology and Treatment Strategies.Biology (Basel)2025https://conductscience.org/library/papers/40906176PubMed
40868052Prenatal Management of Spinal Muscular Atrophy in the Era of Genetic Screening and Emerging Opportunities in In Utero Therapy.Biomedicines2025https://conductscience.org/library/papers/40868052PubMed
40802948Presymptomatic Treatment of a Genetic Disease with a Small-Molecule Drug.N Engl J Med2025https://conductscience.org/library/papers/40802948PubMed
40731766Advances in Fetal Surgery: A Narrative Review of Therapeutic Interventions and Future Directions.Medicina (Kaunas)2025https://conductscience.org/library/papers/40731766PubMed
40603727In utero ASO therapy for spinal muscular atrophy.Nat Rev Drug Discov2025https://conductscience.org/library/papers/40603727PubMed
40570841In utero genetic therapy: Treatment of early onset neurological disorders before they start.Mol Ther2025https://conductscience.org/library/papers/40570841PubMed
40193572In utero therapy for spinal muscular atrophy: closer to clinical translation.Brain2025https://conductscience.org/library/papers/40193572PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SMN16606PubTator's text mininghttps://conductscience.org/library/genes/6606

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40367190

GET https://conductscience.org/api/papers/v1/40367190/authors?page=2